Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04879043
Title Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Heidelberg Pharma AG
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | HUN | DEU


No variant requirements are available.